31
Dec
New Delhi, December 31, 2025— The central government has imposed an immediate nationwide ban on the manufacture, sale and distribution of oral nimesulide tablets containing doses above 100 mg, citing serious concerns related to public health and patient safety. The decision, taken under Section 26A of the Drugs and Cosmetics Act, 1940, comes amid growing scrutiny over the safety profile of the widely used painkiller. According to an official notification issued by the health ministry, oral formulations of nimesulide exceeding the 100 mg limit, including immediate-release tablets, have been found to pose potential risks to human health. Nimesulide, a non-steroidal…